# Preoperative Nebulized Dexmedetomidine Versus Nebulized Magnesium Sulphate in Reducing Emergence Agitation in FESS

> **NCT07677917** · PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Ain Shams University** · enrollment: 50 (estimated)

## Conditions studied

- Screening

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Magnesium sulfate

## Key facts

- **NCT ID:** NCT07677917
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-01-22
- **Primary completion:** 2026-07-22
- **Final completion:** 2027-01-22
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07677917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07677917, "Preoperative Nebulized Dexmedetomidine Versus Nebulized Magnesium Sulphate in Reducing Emergence Agitation in FESS". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07677917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*